|
Volumn 102, Issue 6, 2003, Pages 2310-2311
|
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
INTERLEUKIN 2;
ZOLEDRONIC ACID;
IMIDAZOLE DERIVATIVE;
LYMPHOCYTE ANTIGEN RECEPTOR;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
CANCER PATIENT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG MECHANISM;
EFFECTOR CELL;
FEMALE;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
LETTER;
LYMPHOCYTE FUNCTION;
MALE;
MULTIPLE MYELOMA;
NONHODGKIN LYMPHOMA;
PILOT STUDY;
PRIORITY JOURNAL;
T LYMPHOCYTE;
DRUG EFFECT;
IMMUNOLOGY;
METABOLISM;
DIPHOSPHONATES;
HUMANS;
IMIDAZOLES;
LYMPHOMA, NON-HODGKIN;
MULTIPLE MYELOMA;
RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;
T-LYMPHOCYTES;
|
EID: 0141567513
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood-2003-05-1655 Document Type: Letter |
Times cited : (242)
|
References (6)
|